2025
Integrating TSPO-PET imaging with metabolomics for enhanced prognostic accuracy in multiple sclerosis
Radford-Smith D, Yates A, Kacerova T, Nylund M, Sucksdorff M, Matilainen M, Willemse E, Oechtering J, Maceski A, Leppert D, Kuhle J, Probert F, Anthony D, Airas L. Integrating TSPO-PET imaging with metabolomics for enhanced prognostic accuracy in multiple sclerosis. BMJ Neurology Open 2025, 7: e001026. PMID: 40248672, PMCID: PMC12004482, DOI: 10.1136/bmjno-2025-001026.Peer-Reviewed Original ResearchSecondary progressive MSDisease progressionPET imagingMultiple sclerosisNuclear magnetic resonance (NMR)-based metabolomicsTSPO PET imagingTSPO-PETTSPO imagingMRI-visible lesionsNormal-appearing white matterPrediction of disease progressionPredicting disease progressionClinical trial stratificationSerum metabolite analysisTSPO availabilitySerum metabolomeNMR analysisPrognostic accuracyC-PK11195Progressive MSRelapsing-remittingTreatment strategiesIndependent cohortMetabolites glutamateMS patients
2024
Evaluation of a Novel Prognostic System for Overall Survival in Surgically Resected Oral Cavity Carcinoma
Husain Z, Rybkin A, Lee V, Young M, Eskander A, Burtness B, Park H. Evaluation of a Novel Prognostic System for Overall Survival in Surgically Resected Oral Cavity Carcinoma. International Journal Of Radiation Oncology • Biology • Physics 2024, 120: e759-e760. DOI: 10.1016/j.ijrobp.2024.07.1668.Peer-Reviewed Original ResearchLymphovascular space invasionOral cavity carcinomaOverall survivalIntermediate-riskHigh riskT3/4 diseaseDistant metastasisN stageStandard riskPrediction of distant metastasisGrade 3 tumorsMedian Follow-UpNational Cancer DatabasePathological risk factorsOral cavity cancerKaplan-Meier methodLog-rank testSubsets of patientsHospital-based cohortClinical trial stratificationHigh-volume hospitalsT3/4 tumorsMedian followSurgical resectionIndividualized treatment selection
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply